Literature DB >> 10072625

Reliability of the routine cytological diagnosis in bladder cancer.

A Páez1, J M Coba, N Murillo, P Fernández, M A de la Cal, M Luján, A Berenguer.   

Abstract

OBJECTIVES: To establish the reliability of three cytopathologists for cytological diagnosis of primary bladder tumors.
METHODS: Preoperative voided urine specimens of 71 patients with bladder cancer and 55 noncancer controls were retrospectively and blindly reviewed by 3 independent cytologists, and their results compared. The estimation of the interobserver agreement was calculated using the weighted kappa coefficient. A multivariate analysis was carried out to identify the factors associated with the disagreement between the three observers. The sensitivity and specificity for each of the participants was calculated in order to clearly identify the origin of the disagreement, in terms of the performance of the diagnostic test in the hands of each observer. A comparison of the overall diagnostic performance was made by plotting sensitivity versus 1-specificity.
RESULTS: The weighted kappa coefficient among the 3 observers was 0.46. The multivariate analysis did not identify any variable that could have caused such disagreement. Vast differences in sensitivity and specificity were detected between observer 1 (sens. 0.90, spec. 0.45) and observers 2 (sens. 0.67, spec. 0.72) and 3 (sens. 0.71, spec. 0.80), but the overall diagnostic performance (sensitivity vs. 1-specificity) was superimposable in the 3 cases (p = NS).
CONCLUSIONS: Simple, reproducible and agreed-on-diagnostic criteria should be established to yield reliable results in a group of cytologists. The consideration of individual diagnostic performances can give a false idea of homogeneity between observers. In this field, concordance analysis makes quality control reliable and should be a routine procedure of any pathology department.

Entities:  

Mesh:

Year:  1999        PMID: 10072625     DOI: 10.1159/000019851

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  8 in total

Review 1.  Is there a rationale for bladder cancer screening?

Authors:  Robert S Svatek; Yair Lotan
Journal:  Curr Urol Rep       Date:  2008-09       Impact factor: 3.092

2.  Testis expressed 19 is a novel cancer-testis antigen expressed in bladder cancer.

Authors:  Jianhua Zhong; Yan Chen; Xinhui Liao; Jiaqiang Li; Han Wang; Chenglong Wu; Xiaowen Zou; Gang Yang; Jing Shi; Liya Luo; Litao Liu; Jianping Deng; Aifa Tang
Journal:  Tumour Biol       Date:  2015-12-22

3.  Usefulness of urine cytology as a routine work-up in the detection of recurrence in patients with prior non-muscle-invasive bladder cancer: practicality and cost-effectiveness.

Authors:  Bong Gi Ok; Yoon Seob Ji; Young Hwii Ko; Phil Hyun Song
Journal:  Korean J Urol       Date:  2014-10-10

4.  Urine Cytology as Seen in Uyo, Nigeria: How Relevant Is It to Medical Practice?

Authors:  Chukwuemeka Charles Nwafor; Emmanuel Benjamin Etuk; Kanu Obioha; Elijah A Udoh
Journal:  Niger J Surg       Date:  2020-07-27

5.  [Analyses of the role of immunocytology in the differential diagnosis of patients with asymptomatic microhematuria].

Authors:  B J Schmitz-Dräger; L-A Tirsar; C Schmitz-Dräger; B Beiche; E Bismarck; T Ebert
Journal:  Urologe A       Date:  2008-02       Impact factor: 0.639

6.  Suspicious urinary cytology with negative evaluation for malignancy in the diagnostic investigation of haematuria: how to follow up?

Authors:  G Nabi; D Greene; M O O'Donnell; M O Donnel
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

Review 7.  The Role of Novel Bladder Cancer Diagnostic and Surveillance Biomarkers-What Should a Urologist Really Know?

Authors:  Rafaela Malinaric; Guglielmo Mantica; Lorenzo Lo Monaco; Federico Mariano; Rosario Leonardi; Alchiede Simonato; André Van der Merwe; Carlo Terrone
Journal:  Int J Environ Res Public Health       Date:  2022-08-05       Impact factor: 4.614

8.  Utility of serial urinary cytology in the initial evaluation of the patient with microscopic hematuria.

Authors:  Kogenta Nakamura; Ali Kasraeian; Kenneth A Iczkowski; Myron Chang; John Pendleton; Satoshi Anai; Charles J Rosser
Journal:  BMC Urol       Date:  2009-09-10       Impact factor: 2.264

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.